Injective (INJ) is approaching a critical breakout level at $16, supported by a two-month surge in wallet growth and network activity. The CBOE’s application for a staked INJ ETF signals growing institutional interest. Analysts remain bullish, citing key technical patterns and rising demand.
- CBOE files for SEC approval to list a staked INJ ETF, signaling institutional adoption.
- INJ price action shows a bullish ascending triangle with key resistance at $16.12 (1.0 Fibonacci extension).
- Wallet growth exceeds 4,000, with new participants driving network activity to a two-month high.
📎 Related coverage from: cryptopotato.com
